# Michael McCord

> Michael McCord is a Series A investor at alumshares backing Therapeutics. See 1 investments, check sizes, portfolio and contact details. Updated Oct 2026.

- Type: Angel Investor
- Fund: [alumshares](https://shizune.co/investors/profile/alum-shares)
- Location: Raleigh, United States
- Total investments: 1
- Last investment: Sep 2019
- Lead investor: 100%
- Last updated: Oct 2026
- LinkedIn: https://www.linkedin.com/in/michael-mccord/
- X (Twitter): https://x.com/michaelsmccord
- Website: https://michaelsmccord.com
- Facebook: https://www.facebook.com/mikesmccord

Michael McCord is a Series A investor at alumshares in Raleigh focused on Therapeutics and Biotechnology. Michael McCord is the CEO at Alumshares.

## Contacts

5 contacts available for Michael McCord: work email, personal email, work phone, personal phone and socials. Sign up free to unlock them: https://app.shizune.co/sign-up/investor-profiles/find-email/michael-mccord-2?utm_source=investor_profile

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Therapeutics | 1 | 100% |
| Biotechnology | 1 | 100% |
| Product Research | 1 | 100% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Lindy Biosciences | Lindy Biosciences is a development-stage protein therapeutic formulations company. Our core technology produces spherical, dense, stable particles of a therapeutic protein. These protein particles are ideal for long-term storage, or for non-standard formulations such as suspension formulations (for high-concentration delivery of antibodies),encapsulation (for sustained/controlled release), or dry powder pulmonary delivery.​ | $1.6M | Series A | Sep 18, 2019 | https://www.lindybio.com/ |

1 of 1 investments shown.

## Co-investors
- [BlueTree Allied Angels](https://shizune.co/investors/profile/bluetree-allied-angels) — VC Fund, 1 deal together
- Charleston Angel Conference — VC Fund, 1 deal together
- [IAG Capital Partners](https://shizune.co/investors/profile/iag-capital-partners) — VC Fund, 1 deal together
- [Next Act Fund](https://shizune.co/investors/profile/next-act-fund) — VC Fund, 1 deal together

## About alumshares

VC Fund · Raleigh, United States

alumshares connects alumni of premier research institutions with previously inaccessible investment opportunities at their Alma Mater.

3 contacts available at alumshares.

| Name | Title | Profile |
| --- | --- | --- |
| Michael McCord | CEO | https://shizune.co/investors/profile/michael-mccord-2 |
| Chris Keenan | Principal Software Engineer | https://shizune.co/investors/profile/chris-keenan-2 |
| Omar Flores | PhD | https://shizune.co/investors/profile/omar-flores |

## Similar investors

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [FJ Labs](https://shizune.co/investors/profile/fj-labs) — VC Fund

## FAQ

### What does Michael McCord invest in?

Michael McCord invests primarily in Therapeutics, Biotechnology and Product Research startups, most often at Series A stage. Most of the 1 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### How do I contact Michael McCord?

Public channels for Michael McCord include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

### When did Michael McCord last invest?

The most recent investment recorded for Michael McCord closed in Sep 2019. Shizune tracks 1 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co